Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Watchlist
Price: 58.8 EUR 4.81% Market Closed
Market Cap: 1.2B EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one EUZ stock under the Base Case scenario is 53.14 EUR. Compared to the current market price of 58.8 EUR, Eckert & Ziegler Strahlen und Medizintechnik AG is Overvalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EUZ Relative Value
Base Case
53.14 EUR
Overvaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.4
P/S
P/S
Price to Sales
4.4
vs History
50
vs Industry
30
Median 3Y
3.7
Median 5Y
4.2
Industry
2.2
Forward
4.1
More Details
41.7
P/E
P/E
Price to Earnings
41.7
vs History
33
vs Industry
13
Median 3Y
31.5
Median 5Y
35.4
Industry
21.8
Forward
31.2
More Details
23.2
P/OCF
P/OCF
Price to OCF
23.2
vs History
69
vs Industry
17
Median 3Y
23.7
Median 5Y
25.3
Industry
13.4
More Details
91.1
P/FCFE
P/FCFE
Price to FCFE
91.1
vs History
36
vs Industry
5
Median 3Y
80.1
Median 5Y
77
Industry
19
More Details
4.9
P/B
P/B
Price to Book Value
4.9
vs History
47
vs Industry
17
Median 3Y
4
Median 5Y
4.7
Industry
2.1
More Details
4.2
EV/S
EV/S
Enterprise Value to Sales
4.2
vs History
49
vs Industry
29
Median 3Y
3.6
Median 5Y
4
Industry
2.3
Forward
4
More Details
8.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.8
vs History
49
vs Industry
26
Median 3Y
7.4
Median 5Y
8.4
Industry
4.8
More Details
15.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15.7
vs History
55
vs Industry
23
Median 3Y
14.6
Median 5Y
16.2
Industry
11.4
Forward
16.2
More Details
19.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.4
vs History
63
vs Industry
24
Median 3Y
18.3
Median 5Y
21.1
Industry
15.5
Forward
18.7
More Details
22.2
EV/OCF
EV/OCF
Enterprise Value to OCF
22.2
vs History
68
vs Industry
18
Median 3Y
22.7
Median 5Y
24.1
Industry
13.3
More Details
34.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
34.5
vs History
71
vs Industry
14
Median 3Y
61.3
Median 5Y
57
Industry
17.1
More Details
3.1
EV/IC
EV/IC
Enterprise Value to IC
3.1
vs History
50
vs Industry
27
Median 3Y
2.4
Median 5Y
3
Industry
1.8
More Details

Multiples Across Competitors

EUZ Competitors Multiples
Eckert & Ziegler Strahlen und Medizintechnik AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
1.2B EUR 4.4 41.7 15.7 19.4
US
Abbott Laboratories
NYSE:ABT
223.1B USD 5.3 16.5 21.5 30.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.3B USD 21 74 59 71
US
Boston Scientific Corp
NYSE:BSX
150.3B USD 8.6 73.9 34.9 48.4
US
Stryker Corp
NYSE:SYK
139.2B USD 6.2 46.5 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
108B USD 3.3 25.4 13.6 19.2
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.3 26.4 15.3 21.8
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD 2.9 34 14.5 26.1
US
Edwards Lifesciences Corp
NYSE:EW
44.8B USD 8.1 10.7 24.5 27
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.7B USD 9.2 40.2 28.6 31.9

See Also

Summary
EUZ intrinsic value, competitors valuation, and company profile.
DCF Valuation
EUZ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EUZ stock valuation using valuation multiples.
Wall Street Estimates
EUZ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EUZ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.